Brett Monia is the Chief Executive Officer at Ionis Pharmaceuticals, a company focused on developing medicines for serious diseases.
Brett Monia is the Chief Executive Officer at Ionis Pharmaceuticals, a company focused on developing medicines for serious diseases, particularly in neurology, cardiometabolic, and rare diseases. He joined Ionis as a founding scientist in 1989 and became CEO in 2020. His work has focused on oligonucleotide-based medicines, contributing to the approval of several treatments and the clinical development of numerous others. He has published over 250 research manuscripts and holds more than 100 patents.
Full founder directory · Investor directory · Company funding database · Fundraising library